These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7769190)

  • 61. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease--do we have reliable markers?
    Gelbmann CM
    Inflamm Bowel Dis; 2000 May; 6(2):123-31. PubMed ID: 10833072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study.
    Andus T; Klebl F; Rogler G; Bregenzer N; Schölmerich J; Straub RH
    Aliment Pharmacol Ther; 2003 Feb; 17(3):409-14. PubMed ID: 12562454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitis.
    Jáuregui-Amézaga A; Ricart E; Panés J
    Curr Drug Targets; 2011 Sep; 12(10):1467-77. PubMed ID: 21466495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
    Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 71. How effective are the usual treatments for ulcerative colitis?
    Bebb JR; Scott BB
    Aliment Pharmacol Ther; 2004 Jul; 20(2):143-9. PubMed ID: 15233693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Crohn's disease of the colon.
    Gastroenterology; 1979 Mar; 76(3):607-21. PubMed ID: 34556
    [No Abstract]   [Full Text] [Related]  

  • 73. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Treatment of Crohn's disease].
    Beglinger Ch
    Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Use of parenteral and elementary enteral nutrition in the treatment of Crohn's disease and ulcerative colitis in children].
    Ricour C; Duhamel JF; Nihoul-Fekete C
    Arch Fr Pediatr; 1977; 34(6):505-13. PubMed ID: 410386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Chronic inflammatory bowel diseases].
    Herrlinger K; Stange EF
    Dtsch Med Wochenschr; 2004 Oct; 129(42):2241-50; quiz 2251-4. PubMed ID: 15529447
    [No Abstract]   [Full Text] [Related]  

  • 77. Medical management of Crohn's disease.
    Cottone M; Renna S; Orlando A; Mocciaro F
    Expert Opin Pharmacother; 2011 Nov; 12(16):2505-25. PubMed ID: 21988215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapy of chronic inflammatory bowel diseases].
    Stange EF
    Praxis (Bern 1994); 2002 Nov; 91(47):2029-39. PubMed ID: 12501498
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG; Orchard TR; Jewell DP
    Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U; Maier K; Fischer C; Heinkel K
    N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.